Literature DB >> 6288683

Epstein-Barr virus induction by a serum factor. Characterization of the purified factor and the mechanism of its activation.

G Bauer, P Höfler, M Simon.   

Abstract

Purified Epstein-Barr virus-inducing factor shows all the properties previously described for crude serum, i.e. inducing activity, cooperative activity with the inducers 12-O-tetradecanoyl-phorbol-13-acetate, 5'-iodo-2'-deoxyuridine, N-butyric acid, anti-IgM, and the need to be activated by pH shock. A small subpopulation of untreated factor molecules is fully active, however. The factor is a protein that is characterized by considerable heat resistance and sensitivity to reducing agents. It does not seem to require sugar residues or lipid for its activity. Activation occurs both at alkaline and acidic pH. Inactive and activated factor differ in their sensitivity to trypsin and in the degree of sensitivity to reducing agents. A change of conformation within the molecule seems to be the biochemical basis for the activation reaction.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288683

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Function of the intercistronic region of BRLF1-BZLF1 bicistronic mRNA in translating the zta protein of Epstein-Barr virus.

Authors:  P J Chang; S T Liu
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Promoter sequences required for reactivation of Epstein-Barr virus from latency.

Authors:  Ulrich K Binné; Wolfgang Amon; Paul J Farrell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

3.  Pathways of activation of the Epstein-Barr virus productive cycle.

Authors:  A J Sinclair; M Brimmell; F Shanahan; P J Farrell
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.

Authors:  G J Inman; U K Binné; G A Parker; P J Farrell; M J Allday
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Retrograde Regulation by the Viral Protein Kinase Epigenetically Sustains the Epstein-Barr Virus Latency-to-Lytic Switch To Augment Virus Production.

Authors:  Xiaofan Li; Sergei V Kozlov; Ayman El-Guindy; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

6.  Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter.

Authors:  I K Ruf; D R Rawlins
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

7.  Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency.

Authors:  Helen Bryant; Paul J Farrell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  EBV-inducing factor from platelets exhibits growth-promoting activity for NIH 3T3 cells.

Authors:  G Bauer; U Birnbaum; P Höfler; C H Heldin
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.